You are viewing an incomplete version of our website. Please click to reload the website as full version.

PAP, Prostate Acid Phosphatase antibody

Details for Product No. ABIN93820, Supplier: Log in to see
Clonality (Clone)
Monoclonal ()
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
Log in to see
Supplier Product No.
Log in to see

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Immunogen Purified human Prostate Acid Phosphatase
Clone PAP29
Isotype IgG2a
Specificity Human PAP, 48 kDa subunit, no cross reactivity with PSA
Research Area Cell/Tissue Markers, Cancer
Application Notes IHC(P) , No protease pre-treatment required , neat , Positive Control: Prostate carcinoma
Restrictions For Research Use only
Format Liquid
Buffer stabilizing phosphate buffer pH 7.3. Contains 0.09 % sodium azide. The volume is sufficient for at least 100 immunohistochemical tests (100 ul working solution / test)
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C
Background publications Weinstein MH, Signoretti S, Loda M: "Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells." in: Mod Pathol, Vol. 15, Issue 12, pp. 1302-8, 2002 (PubMed).

Nieder C, Petersen S, Petersen C et al.: "The challenge of p53 as prognostic and predictive factor in Hodgkin's or non-Hodgkin's lymphoma." in: Ann Hematol, Vol. 80, Issue 1, pp. 2-8, 2001 (PubMed).

Nadji, Tabei, Castro et al.: "Prostatic origin of tumors. An immunohistochemical study." in: American journal of clinical pathology, Vol. 73, Issue 6, pp. 735-9, 1980 (PubMed).